Retractable Technologies, Inc. (NYSE:RVP) CEO Buys $10,080.45 in Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw bought 12,445 shares of the firm’s stock in a transaction on Monday, January 27th. The stock was acquired at an average cost of $0.81 per share, with a total value of $10,080.45. Following the completion of the transaction, the chief executive officer now directly owns 15,019,308 shares of the company’s stock, valued at approximately $12,165,639.48. This represents a 0.08 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Retractable Technologies Price Performance

Shares of NYSE:RVP opened at $0.82 on Thursday. The stock has a market capitalization of $24.42 million, a P/E ratio of -1.51 and a beta of 1.94. The business has a 50-day moving average of $0.69 and a two-hundred day moving average of $0.81. Retractable Technologies, Inc. has a fifty-two week low of $0.56 and a fifty-two week high of $1.34. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92.

Analyst Ratings Changes

Separately, StockNews.com assumed coverage on shares of Retractable Technologies in a research note on Thursday. They issued a “hold” rating for the company.

Institutional Investors Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC acquired a new position in Retractable Technologies, Inc. (NYSE:RVP) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies at the end of the most recent quarter. Institutional investors and hedge funds own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.